U.S. FDA Approves First Treatment for Cerebrotendinous Xanthomatosis

February 23, 2025

Tampere University, Theravia Partner to Advance New EB Drug

February 19, 2025

Clinical Trial Update: First Patient Dosed in Phase 1/2a Trial of AGLE-102 in DEB

August 14, 2024

Rare Skin Disease Treatment Update: Transplanting Genetically Healthy Skin to Inflamed Areas May Help Treat EI and IWC

June 10, 2024

Epidermolysis Bullosa: A Clinical Review and Update

May 21, 2024

CBD Cream Shows Promise in EB

May 21, 2024

Congenital Ichthyosis Update

May 14, 2024

PDUFA Delay: FDA Asks for More Information From Abeona for Pz-cel Market Application

April 23, 2024

One-on-One: TDD Talks to Brian Hilberdink, LEO Pharma’s EVP of North America, About Congenital Ichthyosis

March 8, 2024